HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Takashi Tomita Selected Research

Malaria

1/2011Multimodal pyrethroid resistance in malaria vectors, Anopheles gambiae s.s., Anopheles arabiensis, and Anopheles funestus s.s. in western Kenya.
1/2011Distribution of a knockdown resistance mutation (L1014S) in Anopheles gambiae s.s. and Anopheles arabiensis in western and southern Kenya.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Takashi Tomita Research Topics

Disease

4Dengue (Dengue Fever)
12/2022 - 10/2009
3Infections
08/2022 - 01/2015
3Pain (Aches)
02/2022 - 02/2002
3Leukopenia
12/2021 - 11/2016
3Deglutition Disorders (Dysphagia)
01/2021 - 01/2018
2Mania (Manias)
01/2016 - 01/2015
2Hypoglycemia (Reactive Hypoglycemia)
01/2013 - 04/2007
2Malaria
01/2011 - 01/2011
2Anemia
02/2005 - 08/2002
1Ulcer
02/2024
1Arteriosclerosis Obliterans
02/2024
1Wounds and Injuries (Trauma)
02/2024
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
02/2024
1Diabetic Nephropathies (Diabetic Nephropathy)
02/2024
1Schizophrenia (Dementia Praecox)
11/2022
1Weight Gain
11/2022
1Postoperative Pain
08/2022
1Pathologic Constriction (Stenosis)
02/2022
1Hyperglycemia
11/2019
1Acquired Immunodeficiency Syndrome (AIDS)
01/2019
1Breast Neoplasms (Breast Cancer)
01/2018
1Fever (Fevers)
01/2018
1Neoplasms (Cancer)
01/2018
1Stomatitis
01/2018
1Neutropenia
11/2016
1Vomiting
01/2016
1Tick Bites
01/2016
1Alopecia (Baldness)
11/2015
1Mental Disorders (Mental Disorder)
11/2015
1Bipolar Disorder (Manic Depressive Psychosis)
01/2015
1Corneal Injuries
11/2014
1Lice Infestations (Pediculosis)
01/2009
1Japanese Encephalitis
01/2004

Drug/Important Bio-Agent (IBA)

6Pyrethrins (Pyrethroids)FDA Link
08/2014 - 01/2009
5InsecticidesIBA
12/2022 - 01/2004
4Antipsychotic Agents (Antipsychotics)IBA
11/2022 - 11/2016
4Lithium Carbonate (Eskalith)FDA LinkGeneric
12/2021 - 01/2015
2Olanzapine (Zyprexa)FDA Link
11/2022 - 11/2019
2TabletsIBA
01/2019 - 01/2018
2FluoroquinolonesIBA
01/2013 - 04/2007
2Tacrolimus (Prograf)FDA LinkGeneric
02/2005 - 08/2002
1LDL Lipoproteins (beta Lipoproteins)IBA
02/2024
1VancomycinFDA LinkGeneric
02/2024
1oxidized low density lipoproteinIBA
02/2024
1MM 36IBA
02/2022
1Pepsinogen A (Pepsinogen)IBA
01/2022
1Z 338IBA
01/2022
1SolventsIBA
01/2021
1Histamine H1 Receptors (Histamine H1 Receptor)IBA
11/2019
1Serotonin (5 Hydroxytryptamine)IBA
11/2019
1Dopamine (Intropin)FDA LinkGeneric
11/2019
1xanthan gum (xanthan)FDA LinkGeneric
01/2019
1Blood Glucose (Blood Sugar)IBA
01/2019
1voglibose (Basen)IBA
01/2019
1Viral RNAIBA
01/2018
1Antineoplastic Agents (Antineoplastics)IBA
01/2018
1Glutamine (L-Glutamine)FDA Link
01/2018
1Immunoglobulin G (IgG)IBA
01/2018
1Immunoglobulin M (IgM)IBA
01/2018
1Neutralizing AntibodiesIBA
01/2018
1SodiumIBA
01/2018
1pyrimidineIBA
01/2018
1azuleneIBA
01/2018
1Quetiapine Fumarate (Seroquel)FDA Link
01/2017
1Aripiprazole (Abilify)FDA Link
01/2017
1AdenineFDA LinkGeneric
11/2016
1DEET (DET)IBA
01/2016
1Proteins (Proteins, Gene)FDA Link
01/2016
1Valproic Acid (Depakote)FDA LinkGeneric
11/2015
1Anti-Bacterial Agents (Antibiotics)IBA
01/2015
1IodineIBA
11/2014
1Povidone-Iodine (Betadine)FDA LinkGeneric
11/2014
1Adenosine Triphosphate (ATP)IBA
01/2013
1AcetylcholinesteraseIBA
01/2004
1EnzymesIBA
08/2002
1ImmunosorbentsIBA
08/2002
1OrganophosphatesIBA
02/2002
1CarbamatesIBA
02/2002
1Amino AcidsFDA Link
02/2002

Therapy/Procedure

1Therapeutics
02/2024
1Blood Component Removal (Apheresis)
02/2024
1Operative Time
08/2022
1Pedicle Screws
02/2022
1Oral Administration
12/2020
1Drug Therapy (Chemotherapy)
01/2018
1Parenteral Nutrition
01/2016
1Drug Tapering
11/2015
1Mosquito Nets
01/2011
1Insecticide-Treated Bednets
01/2011
1Liver Transplantation
08/2002